Physician profile
Kaadze M Wright
NPI 1053417543
$1,939.46
in general payments reported to CMS, 2019-2025
12 companies · $25.35 in 2025
The $25.35 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $277 · 2020: $279 · 2021: $686 · 2022: $339 · 2023: $197 · 2024: $137 · 2025: $25.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $360.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $359.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $942.83 | 2019-2023 | Linzess, Viberzi, Rinvoq |
| Takeda Pharmaceuticals U.S.A., INC. | $363.96 | 2021-2024 | Entyvio, Gattex |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $253.46 | 2019-2023 | Xifaxan |
| Redhill Biopharma INC. | $104.38 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $92.36 | 2019-2025 | Bridion |
| Qol Medical, LLC | $47.28 | 2023 | Sucraid |
| Daiichi Sankyo INC. | $38.57 | 2020 | |
| Fisher & Paykel Healthcare INC | $23.49 | 2024 | Fisher & Paykel Healthcare |
| Shionogi INC | $22.95 | 2019 | |
| Romark Laboratories, Lc | $20.53 | 2020 | |
| Braintree Laboratories, INC. | $15.37 | 2021 | |
| Intercept Pharmaceuticals, INC. | $14.28 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaadze Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.